Studies have shown that Res may cause IL-6 changes in cells and further downregulate the expression of p-STAT3 and NF-κB [19]; the development of Cis resistance is also associated with the continuously activated p-STAT3 and NF-κB in cancer cells [20, 21]. This evidence concerns the gene NFKB1 and cancer.